A detailed history of Pinnacle Bancorp, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 234 shares of OGN stock, worth $3,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
234
Previous 244 4.1%
Holding current value
$3,411
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$18.65 - $23.03 $186 - $230
-10 Reduced 4.1%
234 $4,000
Q1 2024

Apr 16, 2024

BUY
$13.78 - $18.8 $1,185 - $1,616
86 Added 54.43%
244 $4,000
Q4 2022

Jan 24, 2023

SELL
$23.31 - $28.61 $1,165 - $1,430
-50 Reduced 24.04%
158 $4,000
Q1 2022

Apr 14, 2022

BUY
$30.45 - $39.36 $3,319 - $4,290
109 Added 110.1%
208 $7,000
Q3 2021

Oct 12, 2021

BUY
$28.63 - $35.64 $2,834 - $3,528
99 New
99 $3,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pinnacle Bancorp, Inc. Portfolio

Follow Pinnacle Bancorp, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.